Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Arcidiacono, F.
797  Ergebnisse:
englisch X
Personensuche X
?
1

145P I-SAbR in unresectable LA-NSCLC patients receiving dur..:

Anselmo, P. ; Trippa, F. ; Zannori, C....
ESMO Open.  9 (2024)  - p. 102732 , 2024
Link: https://doi.org/10.1016/..
 
?
2

154P Five-year survival and safety outcomes from the START-..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
ESMO Open.  9 (2024)  - p. 102909 , 2024
Link: https://doi.org/10.1016/..
 
?
3

127P Stereotactic ablative radiotherapy and durvalumab: The..:

Arcidiacono, F. ; Trippa, F. ; Maranzano, E....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S112 , 2023
Link: https://doi.org/10.1016/..
 
?
4

126P Chemotherapy and stereotactic ablative radiotherapy in..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S112 , 2023
Link: https://doi.org/10.1016/..
 
?
5

PRELIMINARY EXPERIENCE OF HALCYON LINAC COMMISSIONING: DOSI..:

Casale, M. ; Italiani, M. ; Fabiani, S....
Physica Medica.  115 (2023)  - p. 102998 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Stereotactic body radiation therapy and abiraterone acetate..:

Francolini, G. ; Detti, B. ; Di Cataldo, V....
European Urology Open Science.  57 (2023)  - p. S157-S158 , 2023
Link: https://doi.org/10.1016/..
 
?
7

OC-0763 SAbR in LA-NSCLC patients unfit for concurrent ChT-..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
Radiotherapy and Oncology.  182 (2023)  - p. S629 , 2023
Link: https://doi.org/10.1016/..
 
?
8

128P Stereotactic ablative radiotherapy in locally-advanced..:

Arcidiacono, F. ; Casale, M. ; Maranzano, E....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S113 , 2023
Link: https://doi.org/10.1016/..
 
?
9

PO-1269 SABR in locally-advanced non-small-cell lung cancer..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
Radiotherapy and Oncology.  170 (2022)  - p. S1070-S1071 , 2022
Link: https://doi.org/10.1016/..
 
?
10

PO-1244 Stereotactic Ablative Radiotherapy In Locally-Advan..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
Radiotherapy and Oncology.  170 (2022)  - p. S1050 , 2022
Link: https://doi.org/10.1016/..
 
?
11

PO-1268 SABR IN LA-NSCLC Elderly Patients Unfit To Concurre..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
Radiotherapy and Oncology.  170 (2022)  - p. S1070 , 2022
Link: https://doi.org/10.1016/..
 
?
12

PO-1243 SABR To Primary Tumor In Oligo-M Nsclc Patients: Go..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
Radiotherapy and Oncology.  170 (2022)  - p. S1050 , 2022
Link: https://doi.org/10.1016/..
 
?
13

PO-1340 Prostate cancer reirradiation with stereotactic V-M..:

Di Marzo, A. ; Trippa, F. ; Anselmo, P....
Radiotherapy and Oncology.  161 (2021)  - p. S1101 , 2021
Link: https://doi.org/10.1016/..
 
?
14

PO-1021: Stereotactic radiotherapy for unresectable locally..:

Arcidiacono, F. ; Anselmo, P. ; Trippa, F....
Radiotherapy and Oncology.  152 (2020)  - p. S545 , 2020
Link: https://doi.org/10.1016/..
 
?
15

OC-0318 10-year clinical and cosmetic outcomes of high-dose..:

Arcidiacono, F. ; Trippa, F. ; Anselmo, P....
Radiotherapy and Oncology.  133 (2019)  - p. S165 , 2019
Link: https://doi.org/10.1016/..
 
1-15